Autonomix Medical, Inc.
AMIXNasdaqCIK 1617867HealthcareFiscal year ends Mar 31
Latest reported revenue, Q1 FY2027$0Revenue, Q1 FY2027, three months to 2026-06-30$0. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027429.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 13, 2026.Latest quarter: Q1 FY2027
Three months to Jun 30, 2026, against the same quarter a year earlier.
- Revenue$0Revenue, Q1 FY2027, three months to 2026-06-30$0. XBRL concept
us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027429.Report this figureSign changed from a year earlier - Gross marginnot reported (Gross profit not reported)No year-earlier figure to compare
- Operating marginnot reported (Revenue of zero not reported)No year-earlier figure to compare
- Net marginnot reported (Revenue of zero not reported)No year-earlier figure to compare
- Diluted EPSnot reported (Diluted EPS not reported)No year-earlier figure to compare
- Free cash flownot reported (Capital expenditure not reported)No year-earlier figure to compare
Last eight quarters
Full statements| Line item | Unit | Q2 FY20252024-09-30 | Q3 FY20252024-12-31 | Q4 FY20252025-03-31 | Q1 FY20262025-06-30 | Q2 FY20262025-09-30 | Q3 FY20262025-12-31 | Q4 FY20262026-03-31 | Q1 FY20272026-06-30 | Shape over the periods |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $k | 0.0Revenue, Q2 FY2025, three months to 2024-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001437749-25-034517.Report this figure | 0.0Revenue, Q3 FY2025, three months to 2024-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-11, accession 0001437749-26-003816.Report this figure | 0.0Revenue, Q4 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-05-27, accession 0001437749-26-018573. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2026, three months to 2025-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027429.Report this figure | 0.0Revenue, Q2 FY2026, three months to 2025-09-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-12, accession 0001437749-25-034517.Report this figure | 0.0Revenue, Q3 FY2026, three months to 2025-12-31$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-02-11, accession 0001437749-26-003816.Report this figure | 0.0Revenue, Q4 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-05-27, accession 0001437749-26-018573. Derived: 12-month figure less the 9-month figure.Report this figure | 0.0Revenue, Q1 FY2027, three months to 2026-06-30$0. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-13, accession 0001437749-26-027429.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | |
| Net margin | % | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | |
| Free cash flow | $k | (1,596)Free cash flow, Q2 FY2025, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: −$1.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034517. Derived: 6-month figure less the 3-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034517. Derived: 6-month figure less the 3-month figure.Report this figure | (2,306)Free cash flow, Q3 FY2025, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: −$2.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001437749-26-003816. Derived: 9-month figure less the 6-month figure.Capital expenditure: $5.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001437749-26-003816. Derived: 9-month figure less the 6-month figure.Report this figure | (8,272)Free cash flow, Q4 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-05-29, accession 0001437749-25-018831.Capital expenditure: $14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-05-29, accession 0001437749-25-018831.Report this figure | (2,604)Free cash flow, Q1 FY2026, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: −$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001437749-26-027429.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-13, accession 0001437749-25-026564.Report this figure | (3,817)Free cash flow, Q2 FY2026, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: −$3.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-12, accession 0001437749-25-034517. Derived: 6-month figure less the 3-month figure.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-12, accession 0001437749-25-034517. Derived: 6-month figure less the 3-month figure.Report this figure | (2,976)Free cash flow, Q3 FY2026, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: −$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-02-11, accession 0001437749-26-003816. Derived: 9-month figure less the 6-month figure.Capital expenditure: $7.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-02-11, accession 0001437749-26-003816. Derived: 9-month figure less the 6-month figure.Report this figure | (2,895)Free cash flow, Q4 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$2.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-27, accession 0001437749-26-018573. Derived: 12-month figure less the 9-month figure.Capital expenditure: $3.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-27, accession 0001437749-26-018573. Derived: 12-month figure less the 9-month figure.Report this figure | not reported (Capital expenditure not reported) |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Last five fiscal years
| Line item | Unit | FY2023-03-31 | FY20242024-03-31 | FY20252025-03-31 | FY20262026-03-31 | Shape over the periods |
|---|---|---|---|---|---|---|
| Revenue | $m | 0.0Revenue, period not labelled, twelve months to 2023-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2024-05-31, accession 0001437749-24-018932.Report this figure | 0.0Revenue, FY2024, twelve months to 2024-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2025-05-29, accession 0001437749-25-018831.Report this figure | 0.0Revenue, FY2025, twelve months to 2025-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-05-27, accession 0001437749-26-018573.Report this figure | 0.0Revenue, FY2026, twelve months to 2026-03-31$0. XBRL concept us-gaap:Revenues. 10-K filed 2026-05-27, accession 0001437749-26-018573.Report this figure | |
| Gross margin | % | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | not reported (Gross profit not reported) | |
| Operating margin | % | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | |
| Net margin | % | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | not reported (Revenue of zero not reported) | |
| Diluted EPS | $ per share | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | not reported (Diluted EPS not reported) | |
| Free cash flow | $m | (1.9)Free cash flow, period not labelled, twelve months to 2023-03-31. operating cash flow − capital expenditureOperating cash flow: −$1.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-05-31, accession 0001437749-24-018932.Capital expenditure: $0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-05-31, accession 0001437749-24-018932.Report this figure | (6.6)Free cash flow, FY2024, twelve months to 2024-03-31. operating cash flow − capital expenditureOperating cash flow: −$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-05-29, accession 0001437749-25-018831.Capital expenditure: $19.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-05-31, accession 0001437749-24-018932.Report this figure | (8.3)Free cash flow, FY2025, twelve months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: −$8.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-27, accession 0001437749-26-018573.Capital expenditure: $14.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-27, accession 0001437749-26-018573.Report this figure | (12.3)Free cash flow, FY2026, twelve months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: −$12.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-05-27, accession 0001437749-26-018573.Capital expenditure: $10.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-05-27, accession 0001437749-26-018573.Report this figure |
Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.
Insider purchases and sales
All insider transactionsThe last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.
No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.
No open-market purchases or sales by insiders are in coverage for this company.
Funds that report holding it
All fundsFrom each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.
| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
|---|---|---|---|---|---|
| Mariner, LLC | 2026-06-30 | $25.6k | 50,138 | New+50,138 | |
| Allied Private Wealth LLC | 2026-06-30 | $2.2k | 347 | Not compared | |
| Tower Research Capital LLC (TRC) | 2026-06-30 | $1.9k | 313 | New+313 | |
| PNC Financial Services Group, Inc. | 2026-06-30 | $467 | 75 | New+75 | |
| Investors Research Corp | 2026-06-30 | $50 | 8 | New+8 | |
| Networth Advisors, LLC | 2026-06-30 | $6 | 1 | New+1 |
Recent filings
All 148 filingsReports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1612:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001437749-26-030505 |
| 2026-09-1421:02 ET | DEF 14A | Proxy statementPeriod 2026-10-29 | 0001437749-26-030345 |
| 2026-08-2621:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-029024 |
| 2026-08-1323:40 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001437749-26-027429 |
| 2026-07-2815:36 ET | 8-K | 8.01 Other events | 0001437749-26-024597 |
| 2026-07-1521:02 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-023638 |
| 2026-07-1012:32 ET | 8-K | 8.01 Other events | 0001437749-26-023248 |
| 2026-06-2411:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-021495 |
| 2026-06-1521:28 ET | 10-K/A | Annual report, amendedPeriod 2026-03-31 | 0001437749-26-020686 |
| 2026-05-2720:30 ET | 10-K | Annual reportPeriod 2026-03-31 | 0001437749-26-018573 |
Latest annual report
Form 10-K for the fiscal year ended Mar 31, 2026Filed May 27, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.
Forecast league
Q2 FY2027, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter
About the filer
- CIK
- 1617867
- Tickers
- AMIX
- Exchange
- Nasdaq
- SIC code
- 3841 Surgical & Medical Instruments & Apparatus
- Sector
- Healthcare
- Fiscal year ends
- Mar 31
- Incorporated in
- DE
- Filer category
- <br>Emerging growth company
Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.